Developer docs
API playgroundTry for free, no card

Search company profiles

LunaDNA

Full company profile

uuid0002hds

Namestring
LunaDNA
Websiteurl
lunadna.com
Company typeenum
Private
Founded yearint
2017
Short descriptiontext

LunaDNA was a San Diego-based health and DNA research platform, founded in 2017, that built a community-owned model allowing individuals to contribute genomic and health data for use by biomedical researchers and industry partners.

Operating statusenum
Closed
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSan Diego, United States
HQ citystring
San Diego
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
DNA research platform, genomic data sharing, personal genomics research, community genomics platform, biomedical data platform
Industry4 codes
1De-identification, Tokenization & Privacy-Preserving Data Platforms
CodeHLACAIAKPrimaryYes
2Genomics & Next-Generation Sequencing (NGS) Services
CodeHLAGANAAPrimaryNo
3Privacy Management (Consent, DSAR, RoPA)
CodeHDADAFAHPrimaryNo
4Sample / Biorepository & Biobank Informatics (Chain-of-Custody)
CodeHLAGAJAHPrimaryNo
NAICS code1 code
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code2 codes
  • In Vitro & In Vivo Diagnostic Substances2835
  • Services-Commercial Physical & Biological Research8731
Product category
Genomic Research Platform
Social media profiles1 record
Cost components4 values
Personnel, Technology or R&D, Marketing or Sales, Operations
GTM typeB2C
B2C
Offering typeSoftware
Software
Core offering1 text field

LunaDNA operates a community-owned health and DNA research platform that enables individuals to share their personal genomic and health data for biomedical research. Members contribute personal data to advance precision medicine and scientific discovery while retaining governance rights over how their information is accessed and used by researchers.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1LunaDNA Platform
CategoryGenomic Research Platform
Description

A community-owned health and DNA research platform that allows individuals to contribute personal genomic and health data for biomedical research while retaining ownership and governance rights over their information.

No data
Peers10 records
1Veritas Genetics
TypeEmerging player
Description

Whole-genome sequencing service with a focus on consumer-driven preventive health. Comparable to LunaDNA on consumer genomics plus downstream data utility, though with a clinical/preventive rather than research-market emphasis.

223andMe
TypeBroad incumbent
Description

Large DTC genetic-testing company with a therapeutics and research arm (23andMe Therapeutics). Operates a research platform that monetizes consented customer data — the same core proposition LunaDNA targets, but at vastly greater scale and with broader product breadth.

3DNAnexus
TypeDirect peer
Description

Cloud-based genomic data management and analysis platform serving researchers and biopharma. Comparable to LunaDNA on the genomic-data-platform layer, though DNAnexus is enterprise/B2B rather than consumer-community-sourced.

4Helix
TypeDirect peer
Description

Population genomics and DNA-sequencing-as-a-service platform with both consumer and research-customer revenue lines. Similar combination of DTC DNA collection plus downstream research/monetization that characterizes LunaDNA's model.

5Genomes.io
TypeEmerging player
Description

Blockchain-based genome data marketplace focused on privacy-preserving, user-controlled genomic data sharing. Direct philosophical and architectural analog to LunaDNA's privacy-first, community-aligned approach.

6Color Genomics
TypeDirect peer
Description

Clinical-grade genetic testing and population-health genomics company. Comparable to LunaDNA on the use of aggregated genomic data to serve both individual consumers and research/clinical partners.

7Human Longevity, Inc.
TypeBroad incumbent
Description

Genomics and health-data company combining whole-genome sequencing with proprietary phenotypic and clinical data. Comparable to LunaDNA in aggregating integrated genomic + phenotypic datasets for research and clinical use.

8Ancestry (AncestryDNA)
TypeBroad incumbent
Description

Largest consumer genealogy and DNA database globally. While not positioned around privacy, its research-data licensing engine is a direct analog to what LunaDNA proposed and underscores the network-effect scale advantages incumbent competitors carry.

9Nebula Genomics
TypeDirect peer
Description

Privacy-focused direct-to-consumer genomic sequencing platform that allows users to contribute data for research under privacy-preserving terms. Most directly comparable to LunaDNA on the combination of DTC DNA access, privacy-by-design architecture, and research-data commercialization.

10EncrypGen
TypeEmerging player
Description

Blockchain-based genomic data marketplace enabling researchers to purchase consented consumer DNA data. Closely aligned with LunaDNA's vision of a decentralized, consent-first genomic research-data exchange.

Market position
Customer concentration

Classification, Details

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors7 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

LunaDNA

Genomic Research Platformlunadna.com

LunaDNA was a San Diego-based health and DNA research platform, founded in 2017, that built a community-owned model allowing individuals to contribute genomic and health data for use by biomedical researchers and industry partners.

LunaDNA firmographics

Firmographics
Name
LunaDNA
Website
https://lunadna.com
Company type
Private
Founded year
2017
Operating status
Closed
Headcount range
11–50 employees
Short description
LunaDNA was a San Diego-based health and DNA research platform, founded in 2017, that built a community-owned model allowing individuals to contribute genomic and health data for use by biomedical researchers and industry partners.
Ownership category
akta.pro rank

LunaDNA industry classification

Industry
Product category
Genomic Research Platform
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
In Vitro & In Vivo Diagnostic Substances (2835), Services-Commercial Physical & Biological Research (8731)
akta.pro primary industry
De-identification, Tokenization & Privacy-Preserving Data Platforms (HLACAIAK)
akta.pro secondary industries
Genomics & Next-Generation Sequencing (NGS) Services (HLAGANAA), Privacy Management (Consent, DSAR, RoPA) (HDADAFAH), Sample / Biorepository & Biobank Informatics (Chain-of-Custody) (HLAGAJAH)

Keywords

  • DNA research platform
  • Genomic data sharing
  • Personal genomics research
  • Community genomics platform
  • Biomedical data platform

Where LunaDNA is headquartered

Location

Headquarters

HQ city
San Diego
HQ country
United States
HQ region
North America

Markets served

LunaDNA business model

Business model
GTM type
B2C
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations

LunaDNA product offering

Product offering

Core offering

LunaDNA operates a community-owned health and DNA research platform that enables individuals to share their personal genomic and health data for biomedical research. Members contribute personal data to advance precision medicine and scientific discovery while retaining governance rights over how their information is accessed and used by researchers.

Differentiator

Problem solved

Functional benefit

Products and services

  • LunaDNA Platform A community-owned health and DNA research platform that allows individuals to contribute personal genomic and health data for biomedical research while retaining ownership and governance rights over their information.

Companies that use LunaDNA

Customer profile

Ideal customer profiles2 records

LunaDNA technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

LunaDNA competitors and assessment

Company assessment

Emerging players

  • Veritas Genetics: Whole-genome sequencing service with a focus on consumer-driven preventive health. Comparable to LunaDNA on consumer genomics plus downstream data utility, though with a clinical/preventive rather than research-market emphasis.
  • Genomes.io: Blockchain-based genome data marketplace focused on privacy-preserving, user-controlled genomic data sharing. Direct philosophical and architectural analog to LunaDNA's privacy-first, community-aligned approach.
  • EncrypGen: Blockchain-based genomic data marketplace enabling researchers to purchase consented consumer DNA data. Closely aligned with LunaDNA's vision of a decentralized, consent-first genomic research-data exchange.

Broad incumbents

  • 23andMe: Large DTC genetic-testing company with a therapeutics and research arm (23andMe Therapeutics). Operates a research platform that monetizes consented customer data — the same core proposition LunaDNA targets, but at vastly greater scale and with broader product breadth.
  • Human Longevity, Inc. Genomics and health-data company combining whole-genome sequencing with proprietary phenotypic and clinical data. Comparable to LunaDNA in aggregating integrated genomic + phenotypic datasets for research and clinical use.
  • Ancestry (AncestryDNA): Largest consumer genealogy and DNA database globally. While not positioned around privacy, its research-data licensing engine is a direct analog to what LunaDNA proposed and underscores the network-effect scale advantages incumbent competitors carry.

Direct peers

  • DNAnexus: Cloud-based genomic data management and analysis platform serving researchers and biopharma. Comparable to LunaDNA on the genomic-data-platform layer, though DNAnexus is enterprise/B2B rather than consumer-community-sourced.
  • Helix: Population genomics and DNA-sequencing-as-a-service platform with both consumer and research-customer revenue lines. Similar combination of DTC DNA collection plus downstream research/monetization that characterizes LunaDNA's model.
  • Color Genomics: Clinical-grade genetic testing and population-health genomics company. Comparable to LunaDNA on the use of aggregated genomic data to serve both individual consumers and research/clinical partners.
  • Nebula Genomics: Privacy-focused direct-to-consumer genomic sequencing platform that allows users to contribute data for research under privacy-preserving terms. Most directly comparable to LunaDNA on the combination of DTC DNA access, privacy-by-design architecture, and research-data commercialization.

Market position

Customer concentration

LunaDNA social profiles

Digital presence

LunaDNA financial estimates

Financial estimate

Revenue estimate

Valuation estimate

LunaDNA leadership team

Management profile

Number of profiles

Profiles7 records

LunaDNA funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

LunaDNA M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LunaDNA

What does LunaDNA do?

LunaDNA operates a community-owned health and DNA research platform that enables individuals to share their personal genomic and health data for biomedical research. Members contribute personal data to advance precision medicine and scientific discovery while retaining governance rights over how their information is accessed and used by researchers.

When was LunaDNA founded?

LunaDNA was founded in 2017. It employs 11 to 50 people.

Where is LunaDNA based?

LunaDNA is headquartered in San Diego, United States, in the North America region.

Who are LunaDNA's main competitors?

Emerging players on record are Veritas Genetics, Genomes.io and EncrypGen. Broad incumbents are 23andMe, Human Longevity, Inc. and Ancestry (AncestryDNA). Direct peers are DNAnexus, Helix, Color Genomics and Nebula Genomics.

Does LunaDNA have an API?

No public API is recorded for LunaDNA.

What industry is LunaDNA in?

LunaDNA's product category is Genomic Research Platform. Its primary akta.pro industry code is HLACAIAK, De-identification, Tokenization & Privacy-Preserving Data Platforms, with a secondary code of HLAGANAA, Genomics & Next-Generation Sequencing (NGS) Services. Its NAICS code is 541714 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
InsideprecisionmedicineTotal Eclipse of LunaDNA: Once Touted Genome Data Sharing Platform Goes DarkLunaDNA, a San Diego-based company known for being the first member-owned data-sharing platform for health research, is set to close on January 31, 2024, due to a critical shortage of funds amidst a challenging economic environment. The company previously indicated financial struggles, revealing that it had no cash or liquid assets as of June 30, 2022, and lacked plans to raise additional capital. This closure highlights the difficulties faced by innovative companies in securing funding within the biotech sector.Business InsiderVCs just bet $3.5 billion that tech will transform the future of healthcare. These are the top 9 firms making the most digital health investments.VCs invested $3.5 billion in about 371 digital health deals in Q2 2019, with nine firms leading. The report does not disclose the number of unique investments per firm, but names companies like Alma Health, Omada, and LunaDNA.PR NewswireBlockchain in Genomic Data Management - Worldwide Markets, 2018-2030: It is Estimated that by 2025, Around 15% of the World's Population will Have had Their Genomes SequencedResearchAndMarkets.com published a market research report on blockchain platforms for genomic data management, projecting that by 2025 around 15% of the world's population will have had their genomes sequenced. The market is currently niche with over 35% of players based in North America, primarily in the US, including EncrypGen, GnoMine, LunaDNA, and Nebula Genomics, while companies are also present in Brazil, India, Israel, Russia, Singapore, and South Korea. The report estimates the market will grow at an annualized rate of 43.5% between 2018 and 2030, with the current coin market capitalization valued between USD 400-750 million, and social media sentiment analysis showing 85% positive tweets about the technology.PR NewswireLunaDNA Offering Qualified as the World's First Health and DNA Data Platform to Offer Ownership Shares to Individuals for Sharing DataLunaDNA LLC announced that its securities offering has been qualified by the SEC and its platform is now open to U.S. residents, becoming the first community-owned health and DNA data platform to offer ownership shares in exchange for contributing personal health information. Members can earn shares by contributing DNA data files from services such as 23andMe, AncestryDNA, and MyHeritage, and increase their holdings by contributing more data over time. LunaDNA's model allows researchers to query de-identified, aggregated health data with member consent, while members retain control over their data and participate in financial value through dividends.FinSMEsLuna DNA Raises $4M in Total FundingLuna DNA, a Solana Beach-based genomic research database, raised additional funding from Illumina Ventures, Arch Venture Partners, Bridgelink Capital, Hemisphere Ventures, and Dr. Aristides Patrinos. The financing brings total funding to $4M, which the company will use to expand operations and develop its platform.FinSMEsLuna DNA Raises $2M in Seed FundingLuna DNA, a San Diego-based genomic research platform, raised $2M in seed funding from individual investors and former Illumina executives. The company's community-owned database rewards contributors with Luna Coins, a blockchain-based token, and aims to aggregate DNA data from multiple sources.